Suppr超能文献

人体挥发物组:呼出气、皮肤散发物、尿液、粪便和唾液中的挥发性有机化合物(VOCs)

The human volatilome: volatile organic compounds (VOCs) in exhaled breath, skin emanations, urine, feces and saliva.

作者信息

Amann Anton, Costello Ben de Lacy, Miekisch Wolfram, Schubert Jochen, Buszewski Bogusław, Pleil Joachim, Ratcliffe Norman, Risby Terence

机构信息

Univ-Clinic for Anesthesia and Intensive Care, Innsbruck Medical University, Anichstr, 35, A-6020 Innsbruck, Austria. Breath Research Institute of the University of Innsbruck, Rathausplatz 4, A-6850 Dornbirn, Austria.

出版信息

J Breath Res. 2014 Sep;8(3):034001. doi: 10.1088/1752-7155/8/3/034001. Epub 2014 Jun 19.

Abstract

Breath analysis is a young field of research with its roots in antiquity. Antoine Lavoisier discovered carbon dioxide in exhaled breath during the period 1777-1783, Wilhelm (Vilém) Petters discovered acetone in breath in 1857 and Johannes Müller reported the first quantitative measurements of acetone in 1898. A recent review reported 1765 volatile compounds appearing in exhaled breath, skin emanations, urine, saliva, human breast milk, blood and feces. For a large number of compounds, real-time analysis of exhaled breath or skin emanations has been performed, e.g., during exertion of effort on a stationary bicycle or during sleep. Volatile compounds in exhaled breath, which record historical exposure, are called the 'exposome'. Changes in biogenic volatile organic compound concentrations can be used to mirror metabolic or (patho)physiological processes in the whole body or blood concentrations of drugs (e.g. propofol) in clinical settings-even during artificial ventilation or during surgery. Also compounds released by bacterial strains like Pseudomonas aeruginosa or Streptococcus pneumonia could be very interesting. Methyl methacrylate (CAS 80-62-6), for example, was observed in the headspace of Streptococcus pneumonia in concentrations up to 1420 ppb. Fecal volatiles have been implicated in differentiating certain infectious bowel diseases such as Clostridium difficile, Campylobacter, Salmonella and Cholera. They have also been used to differentiate other non-infectious conditions such as irritable bowel syndrome and inflammatory bowel disease. In addition, alterations in urine volatiles have been used to detect urinary tract infections, bladder, prostate and other cancers. Peroxidation of lipids and other biomolecules by reactive oxygen species produce volatile compounds like ethane and 1-pentane. Noninvasive detection and therapeutic monitoring of oxidative stress would be highly desirable in autoimmunological, neurological, inflammatory diseases and cancer, but also during surgery and in intensive care units. The investigation of cell cultures opens up new possibilities for elucidation of the biochemical background of volatile compounds. In future studies, combined investigations of a particular compound with regard to human matrices such as breath, urine, saliva and cell culture investigations will lead to novel scientific progress in the field.

摘要

呼吸分析是一个起源于古代的年轻研究领域。安托万·拉瓦锡在1777年至1783年期间发现呼出气体中的二氧化碳,威廉(维莱姆)·彼得斯于1857年发现呼出气体中的丙酮,约翰内斯·米勒在1898年报告了丙酮的首次定量测量。最近的一篇综述报道,呼出气体、皮肤散发物、尿液、唾液、人乳、血液和粪便中出现了1765种挥发性化合物。对于大量化合物,已经进行了呼出气体或皮肤散发物的实时分析,例如在固定自行车上用力时或睡眠期间。呼出气体中的挥发性化合物记录了历史暴露情况,被称为“暴露组”。生物源挥发性有机化合物浓度的变化可用于反映全身的代谢或(病理)生理过程,或临床环境中药物(如丙泊酚)的血药浓度——即使在人工通气或手术期间也是如此。像铜绿假单胞菌或肺炎链球菌等细菌菌株释放的化合物也可能非常有趣。例如,在肺炎链球菌的顶空中观察到甲基丙烯酸甲酯(CAS 80-62-6)的浓度高达1420 ppb。粪便挥发物与区分某些感染性肠道疾病有关,如艰难梭菌、弯曲杆菌、沙门氏菌和霍乱。它们也被用于区分其他非感染性疾病,如肠易激综合征和炎症性肠病。此外,尿液挥发物的变化已被用于检测尿路感染、膀胱癌、前列腺癌和其他癌症。活性氧对脂质和其他生物分子的过氧化作用会产生乙烷和1-戊烷等挥发性化合物 在自身免疫性、神经学、炎症性疾病和癌症中,以及在手术期间和重症监护病房中,对氧化应激进行无创检测和治疗监测将非常有必要。对细胞培养的研究为阐明挥发性化合物的生化背景开辟了新的可能性。在未来的研究中,对特定化合物在人体基质(如呼吸、尿液、唾液)方面的联合研究以及细胞培养研究将在该领域带来新的科学进展。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验